CBD market growth over the next ten years will outpace marijuana growth by more than 12-to-one
By the end of this decade, projections are that the CBD market will expand 25-fold, from roughly $2 billion today to over $50 billion! Compared to the marijuana industry forecast to expand only 2 fold in the same time period.
Many cannabis investors are missing the future in this market by micro focusing on marijuana production. They’re overlooking the far bigger story that’s building in hemp production, the source plant for CBD extracts.
While recreational marijuana has been around virtually forever…the market for CBD extracts is still in its infancy…and it’s on a fast track to a $50 billion heavyweight outcome.
The numbers are stunning… and the investment potential more than obvious. CBD market growth is projected to outpace THC market growth by more than 12-to-one.
This article explains the huge discrepancy between the two sides of the cannabis market. And why, based on growth opportunity alone, you should immediately shift your attention to the CBD side of the market.
More important, it explains how one little-known company, is positioned to evolve into one of the most important and largest producers of high purity CBD extracts in the world.
The market now pays and will likely continue to pay stunning prices for the best grades in CBD extracts…better, in fact, than THC.
When it comes to CBD, it’s all about purity and it has to be flawless.
When CBD meets the highest standards for purity, extracts can sell for upwards to $850 an ounce.[1] To get those kind of prices requires stringent quality control through the entire farm to market process.
The company we’ve chosen as our top CBD pick for 2020 is one of the very few worldwide that can pull this off. Everything is managed and controlled internally to produce the purest form of CBD extracts available anywhere.
While many have entered the Cannabis space over the past few years and many have left, this little-known company is here for the long haul. It has spent the past few years building one of the industries most complete infrastructures and is now poised to capitalize on what it has achieved. With quality hemp, extraction, testing, and formulation, along with packaging and retail this undervalued company is the perfect storm.
And right now they are embarking on its biggest expansion yet. The Company reports that it is now capable of producing up to 1.4 million ounces of high purity CBD extracts per year!
How valuable is that? It can be better than owning a gold mine!
Simple math shows that CBD can generate larger, virtually unending revenue streams with substantially lower capital expenditures (CAPEX) and production costs than mining for gold.
A gold mine with a million ounces in reserves may generate $1.5 to $3.0 million net annual revenue over the limited life of the mine.
CBD production, by comparison, has no life limitation. What’s more, and most importantly, 1.4 million ounces of high-purity CBD extract could generate $20 to $30 million net revenue annually!
That’s up to ten-times the potential from mining gold!
And there’s no end to it! This company’s 1.4 million ounce CBD production target of CBD per year can be ongoing for decades…it’s only a starting point!
Their current production target is limited only by the CBD content of the raw hemp it processes. As more higher CBD content strains of hemp are developed, annual production CBD extracts could double, triple or more annually.
Again, look at the meteoric growth curve projected for CBD extracts. And it’s not just for anything that can be labeled CBD. As a pharmaceutical product, CBD must be expertly extracted, labeled accurately and produced at the highest grade of purity.
The medicinal potential in CBD compounds extends from over-the-counter medications to disease-targeting prescription pharmaceuticals. Regardless of intended use, the quality must be absolute and the supply scalable to the need. Lives will depend on both.
Keep in mind that there are dozens of CBD like molecules that can be extracted from the hemp plant…and many of these unique molecules carry very different pharmaceutical potential (over 85 cannabinoids have been identified to date).z
This PubMed report issued through the National Library of Medicine, National Institute of Health points to the vital importance of pure, highly targeted CBD extraction.[2] That purity, so essential to pharmaceutical use, may only be made possible through the tightly controlled, vertically integrated processes.
“Cannabidiol, or CBD, is one of at least 85 active cannabinoids identified within the Cannabis plant. It is a major phytocannabinoid, accounting for up to 40% of the [hemp] plant’s extract, that binds to a wide variety of physiological targets of the endocannabinoid system within the body.”
“CBD has shown promise as an analgesic, anticonvulsant, muscle relaxant, anxiolytic, antipsychotic and has shown neuroprotective, anti-inflammatory, and antioxidant activity, among other currently investigated uses.”
Now is the time to get in front of this.
For an investor, particularly now at the entry-level stage, production scaling can lead to enormous gains in the years ahead. Sign up to receive more information about this innovative young company that is poised to take the lead.
(20min delay)